Excelra

R&D

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

News

Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.